Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic Bacterial Vaccine Against COVID-19 Through Exclusive Option Agreement with Julius-Maximilians-University Wuerzburg - Company secures next step to continue to build-out pipeline of assets. - University researchers developed a proprietary and orally active bacterial vaccine...
AditxtScore™ Immune Monitoring Service Will be Operational on February 1st Company Plans to Offer Service through Channel Partners The initial application of the platform will be AditxtScore™ for COVID-19 which has been designed to provide a more complete assessment of an individual’s infection and immunity status with respect to the SARS-CoV-2 virus. We’re...
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19 announced today the submission of an Investigational New Drug (IND) to FDA for the investigational use of Tempol for the treatment of Coronavirus (COVID-19). The submission of the IND to FDA followed a Pre-IND meeting with FDA in which FDA gave specific...
GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company a Small Business Innovative Research (SBIR) grant in support of its development of a vaccine against SARS-CoV-2, the virus that causes...
This is not just a penny stock, but also a good investment for long term, however if you're not planning to hold for long term, then I suggest you to take profits on each target level. -- Do your research and trade on your own risk!
My last chart: November 22, 2020: Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA (The Motley Fool). Regeneron Covid Drug Gets Emergency OK. Antibody drug cocktail casirivimab and imdevimab are allowed for use by people over age 12 with mild or moderate Covid-19. (the street). If you are interested...
The TA should speak for itself. The current uptrend for COLM shows a continuation of the bullish recovery for this stock. In addition, look at the macro-economic environment. With impending social restrictions caused by Covid-19s resurgence across the USA, and temperatures dropping, this is the logical time to invest in Winter Outerwear. Local...
I am in at $2.35. - Oversold, RSI @ 21 - $9.5 USD financing just closed at $3.10 CDN with insiders/institutions buying ahead of COVID-19 treatment Phase 2 trial results - Will need to maintain $4+ stock price to stay listed on NASDAQ - Gaps above at 3.33 & 5.56 - Signs of bottoming out - $25M in cash; with Cannabis asset sale (~$20M), the cash position will exceed...
Crossed 20 EMA RSI close to midpoint 53.34 only problem is volume seems rather low Popular games on their roster include: NBA 2K, WWE 2K, GTA, RDR, Sid Meyer Civilization These are just my observations and not meant to be taken as financial advice.
identifying patterns. can see how the mac D on total us deaths is starting to turn bearish, i can see a slowdown happen around election day @ 225000 deaths could peak a few months past into new years @ 285000 deaths before really starting to flatline the squeeze indicator is also showing slowdown in confirmed deaths. we are hitting the top of the ascending wedge,...
CODX is a COVID stock (testing services) Has a history of multy-day breakouts; now on the bottom Made 40% on news yesterday on 20 mln daily volume Can easily go up Next target 15, then 20 if momentum continues
Identical setup to my Aug 6th call that resulted in 70% profit. Strong support at EMA 50 and oversold on the Hourly. Possibility of news tomorrow or Friday. Stop loss under today’s low.
Relief Therapeutics Holding AG, a clinical stage biotechnology company, engages in developing treatment solutions for indications related to diabetic complications and respiratory diseases. The company is developing aviptadil, which has completed Phase II clinical trial for the treatment of sarcoidosis, an orphan pulmonary disease, as well as pulmonary...